StockSelector.com
  Research, Select, & Monitor Tuesday, January 21, 2020 11:41:12 PM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Aerie Pharmaceuticals, Inc.$22.56($.18)(.79%)

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Aerie Pharmaceuticals, Inc. has an overall rank of 5855 out of 6306 stocks based on 4 positive rankings and 6 negative rankings.

Positive Rankings
Target Prices
The average analysts' target price is $36.80 for Aerie Pharmaceuticals using target prices set or adjusted within the past 90 days. Among companies with recent target prices and with the average above the current stock price, Aerie Pharmaceuticals is ranked 95.
Oversold Stochastics
Aerie Pharmaceuticals rank is 487
Low Put/Call
Aerie Pharmaceuticals has a low Put/Call ratio of 0.28 on all open interest of options expiring in the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Aerie Pharmaceuticals is ranked 764.
90 Day Gain
Aerie Pharmaceuticals rank is 2658
Negative Rankings
Down EPS Surprise
Aerie Pharmaceuticals missed the consensus earnings estimate when it last reported quarterly earnings.
Negative Guidance
Within the past 90 days Aerie Pharmaceuticals has provided guidance belwo the consensus estimates. Statistics show companies that provide negative guidance underperform the market in the short-term.
High/Dropping MACD
The MACD remains positive, but is dropping... suggesting a possible near-term correction. Of companies with a positive, but declining MACD, Aerie Pharmaceuticals is ranked 286.
Down Ratings Revision
During the past month, the average analyst's rating or recommendation has decreased. Among companies that have been downgraded within the past month, Aerie Pharmaceuticals is ranked 295.
10 Day Loss
Aerie Pharmaceuticals rank is 698
High vPut/Call
Aerie Pharmaceuticals has a high Put/Call ratio of 0.23 on active options expiring within the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Aerie Pharmaceuticals is ranked 1342.







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2020 StockSelector.com. All rights reserved.